Monthly Archives: March 2017

Inside Israel: The Start-Up Nation Looks East For Investment

06 Mar 2017 ANALYSIS Health IT is set to be one of the subjects explored at the MIXiii BIOMED annual conference, Israel's leading international life science industry conference. The conference, now in its 16th year, will be held in Tel Aviv in May and is expected to attract over 6,000 participants. This year the leading theme [...]

By |2018-11-20T08:52:51+00:00March 8th, 2017|Blog|Comments Off on Inside Israel: The Start-Up Nation Looks East For Investment

Cnoga Medical raises $50m from China’s BOE

 6 Mar, 2017 Gali Weinreb Cnoga's non-invasive devices measure health through optical diagnosis of the changing color shades of a finger. Chinese company BOE has invested $50 million in Israeli company Cnoga Medical for 23% of the company's shares, reflecting a company value of $217 million, the two companies today reported. The shares given to [...]

By |2018-11-20T08:53:02+00:00March 7th, 2017|Blog|Comments Off on Cnoga Medical raises $50m from China’s BOE

NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Based on iNDiGO Trial Following EMA Meeting

- Trial 006 demonstrated a statistically significant and clinically meaningful reduction in OFF-time and increase in proportion of patients “ON” by 8:00 am (primary and key secondary endpoints) - - The trial also showed statistically significant reduction in troublesome dyskinesia and a complete reduction of OFF-time to zero hours in 66% of responders (post hoc [...]

By |2018-11-20T08:53:30+00:00March 6th, 2017|Blog|Comments Off on NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Based on iNDiGO Trial Following EMA Meeting

Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers

JERUSALEM, Feb. 28, 2017 /PRNewswire/ -- Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the first patient has been transplanted in the Company's Phase 3 study of NiCord®, in development as a cure for patients with blood cancer who do not have [...]

By |2018-11-20T08:54:16+00:00March 6th, 2017|Blog|Comments Off on Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers

#Biomed2017 – XACT Robotics raises $5m

10 Aug, 2015 15:07 Gali Weinreb The Israeli company will use the investment to fund US trials for its needle steering technology. XACT Robotics, an Israeli startup developing novel platform robotic technology for use in minimally invasive procedures has raised $5 million. The latest round of funding was led by MEDX Ventures Group, which founded [...]

By |2018-11-20T08:54:23+00:00March 5th, 2017|Blog|Comments Off on #Biomed2017 – XACT Robotics raises $5m

Medisafe Takes In $14.5M to Help Patients Manage Medications

Prescriptions can be complicated and confusing, especially for patients taking more than one set of pills. But when people don’t properly follow their prescription plans, it can lead to deteriorating health, additional hospital visits, and potentially life-threatening episodes. The costs are high for the healthcare industry, too. Studies have estimated that more than $100 billion [...]

By |2018-11-20T08:54:38+00:00March 5th, 2017|Blog|Comments Off on Medisafe Takes In $14.5M to Help Patients Manage Medications